On the growth and form of the gut

The developing vertebrate gut tube forms a reproducible looped pattern as it grows into the body cavity. Here we use developmental experiments to eliminate alternative models and show that gut looping morphogenesis is driven by the homogeneous and isotropic forces that arise from the relative growth between the gut tube and the anchoring dorsal mesenteric sheet, tissues that grow at different rates. A simple physical mimic, using a differentially strained composite of a pliable rubber tube and a soft latex sheet is consistent with this mechanism and produces similar patterns. We devise a mathematical theory and a computational model for the number, size and shape of intestinal loops based solely on the measurable geometry, elasticity and relative growth of the tissues. The predictions of our theory are quantitatively consistent with observations of intestinal loops at different stages of development in the chick embryo. Our model also accounts for the qualitative and quantitative variation in the distinct gut looping patterns seen in a variety of species including quail, finch and mouse, illuminating how the simple macroscopic mechanics of differential growth drives the morphology of the developing gut.     

Myelin-associated proteins block the migration of olfactory ensheathing cells: an in vitro study using single-cell tracking and traction force microscopy

Newly generated olfactory receptor axons grow from the peripheral to the central nervous system aided by olfactory ensheathing cells (OECs). Thus, OEC transplantation has emerged as a promising therapy for spinal cord injuries and for other neural diseases. However, these cells do not present a uniform population, but instead a functionally heterogeneous population that exhibits a variety of responses including adhesion, repulsion, and crossover during cell–cell and cell–matrix interactions. Some studies report that the migratory properties of OECs are compromised by inhibitory molecules and potentiated by chemical gradients. Here, we demonstrated that rodent OECs express all the components of the Nogo receptor complex and that their migration is blocked by myelin. Next, we used cell tracking and traction force microscopy to analyze OEC migration and its mechanical properties over myelin. Our data relate the decrease of traction force of OEC with lower migratory capacity over myelin, which correlates with changes in the F-actin cytoskeleton and focal adhesion distribution. Lastly, OEC traction force and migratory capacity is enhanced after cell incubation with the Nogo receptor inhibitor NEP1-40.     

The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells

A therapeutic strategy for treating cancer is to target and eradicate cancer stem cells (CSCs) without harming their normal stem cell counterparts. The success of this approach relies on the identification of molecular pathways that selectively regulate CSC function. Using BCR-ABL-induced chronic myeloid leukemia (CML) as a disease model for CSCs, we show that BCR-ABL downregulates the Blk gene (encoding B-lymphoid kinase) through c-Myc in leukemic stem cells (LSCs) in CML mice and that Blk functions as a tumor suppressor in LSCs but does not affect normal hematopoietic stem cells (HSCs) or hematopoiesis. Blk suppresses LSC function through a pathway involving an upstream regulator, Pax5, and a downstream effector, p27. Inhibition of this Blk pathway accelerates CML development, whereas increased activity of the Blk pathway delays CML development. Blk also suppresses the proliferation of human CML stem cells. Our results show the feasibility of selectively targeting LSCs, an approach that should be applicable to other cancers.     

Using human pluripotent stem cells to untangle neurodegenerative disease mechanisms

Human pluripotent stem cells, including embryonic (hES) and induced pluripotent stem cells (hiPS), retain the ability to self-renew indefinitely, while maintaining the capacity to differentiate into all cell types of the nervous system. While human pluripotent cell-based therapies are unlikely to arise soon, these cells can currently be used as an inexhaustible source of committed neurons to perform high-throughput screening and safety testing of new candidate drugs. Here, we describe critically the available methods and molecular factors that are used to direct the differentiation of hES or hiPS into specific neurons. In addition, we discuss how the availability of patient-specific hiPS offers a unique opportunity to model inheritable neurodegenerative diseases and untangle their pathological mechanisms, or to validate drugs that would prevent the onset or the progression of these neurological disorders.     

Abnormally soluble collagen produced in fibroblasts cultures

Summary Abnormally soluble collagen is synthesized in vitro not only by skin fibroblasts of Marfan patients but also by those of patients with Ehlers-Danlos type V and cutis laxa. The excessive solubility of collagen is corrected by the addition to the culture medium of a synthetic flavonoid, (+)-catechin.Supported by grants from the National Institutes of Health (Nos. AM-10811, HL-05435, GM-19513 and GM-00081), the National Fondation-March of Dimes, and Zyma, S.A., Nyon, Switzerland.     

Spreading rate dependence of gravity anomalies along oceanic transform faults

Mid-ocean ridge morphology and crustal accretion are known to depend on the spreading rate of the ridge. Slow-spreading mid-ocean-ridge segments exhibit significant crustal thinning towards transform and non-transform offsets, which is thought to arise from a three-dimensional process of buoyant mantle upwelling and melt migration focused beneath the centres of ridge segments. In contrast, fast-spreading mid-ocean ridges are characterized by smaller, segment-scale variations in crustal thickness, which reflect more uniform mantle upwelling beneath the ridge axis. Here we present a systematic study of the residual mantle Bouguer gravity anomaly of 19 oceanic transform faults that reveals a strong correlation between gravity signature and spreading rate. Previous studies have shown that slow-slipping transform faults are marked by more positive gravity anomalies than their adjacent ridge segments, but our analysis reveals that intermediate and fast-slipping transform faults exhibit more negative gravity anomalies than their adjacent ridge segments. This finding indicates that there is a mass deficit at intermediate- and fast-slipping transform faults, which could reflect increased rock porosity, serpentinization of mantle peridotite, and/or crustal thickening. The most negative anomalies correspond to topographic highs flanking the transform faults, rather than to transform troughs (where deformation is probably focused and porosity and alteration are expected to be greatest), indicating that crustal thickening could be an important contributor to the negative gravity anomalies observed. This finding in turn suggests that three-dimensional magma accretion may occur near intermediate- and fast-slipping transform faults.     

Geochronology: age of Mexican ash with alleged 'footprints'

A report of human footprints preserved in 40,000-year-old volcanic ash near Puebla, Mexico (http://www.royalsoc.ac.uk/exhibit.asp?id=3616&tip=1), was the subject of a press conference that stirred international media attention. If the claims (http://www.mexicanfootprints.co.uk) of Gonzalez et al. are valid, prevailing theories about the timing of human migration into the Americas would need significant revision. Here we show by 40Ar/39Ar dating and corroborating palaeomagnetic data that the basaltic tuff on which the purported footprints are found is 1.30+/-0.03 million years old. We conclude that either hominid migration into the Americas occurred very much earlier than previously believed, or that the features in question were not made by humans on recently erupted ash.     

The effect of dietary amino acids on the growth of tumors

Summary In C3H mice, a direct dose response relationship between tumor growth and dietary amino acid is seen for fibrosarcoma and mammary carcinoma, extending over a range the lower limit of which is defined by the minimum amino acid requirements, and the upper limit by the amino acid level found in most stock diets.Supported by Medical Research Council of Canada.